Status:
COMPLETED
A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations
Lead Sponsor:
Aevi Genomic Medicine, LLC, a Cerecor company
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
6-17 years
Brief Summary
This is a non-interventional study in children and adolescents (ages 6-17 years) with attention deficit hyperactivity disorder (ADHD) to assess CNVs in specific genes involved in glutamatergic signali...
Eligibility Criteria
Inclusion
- Parent/legally authorized representative (LAR) can speak and read English fluently, have provided informed consent and agree to be contacted for an interventional study prior to being genotyped.
- Subject is 6 to 17 years of age (inclusive) at the time of informed consent.
- Parent/LAR confirms that the subject has been diagnosed with or been told by a doctor that their child has ADHD.
- Parent/LAR confirms that the subject is not pregnant and/or breastfeeding.
Exclusion
- Parent/LAR confirms that the subject has been diagnosed with any of the following conditions (aside from ADHD): conduct disorder, anxiety disorder, major depression, autism spectrum disorder (ASD), bipolar disease, psychosis, hypertension, seizure disorder, syncope, or other serious cardiac problems.
- Aside from your child's current ADHD medication (if applicable), parent/LAR confirms that the subject is currently taking any of the following medications: antidepressants, anti-anxiety medications, anti-psychotics, and/or mood stabilizers.
- Parent/LAR confirms that the subject has been genotyped previously in the MDGN-NFC1-ADHD-001, MDGN-NFC1-ADHD-101 clinical study.
Key Trial Info
Start Date :
August 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 3 2018
Estimated Enrollment :
2503 Patients enrolled
Trial Details
Trial ID
NCT03233867
Start Date
August 14 2017
End Date
August 3 2018
Last Update
July 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aevi Genomic Medicine
Wayne, Pennsylvania, United States, 19087